Filing is Based On the Company's US Provisional Patent Filed in October 2014
DENVER, CO / ACCESSWIRE / March 17, 2016 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis"), the creator of Prana Bio Nutrient Medicinals, today announced that it filed an international patent application, pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using Same."
This application is another step in the United Cannabis' mission to protect its intellectual property and follows on the 2014 acceptance of its provisional and then non-provisional utility patent applications for its proprietary processes.
Tony Verzura, United Cannabis' Chief Technology Officer commented on the filing, "As the interest in cannabinoid-based products continues to build, we are seeing an increase in the number of inquiries regarding our Prana line and the underlying technologies. This application not only provides international protection of our proprietary processes, it will also enable us to capitalize on our work though the safe licensing of these technologies to interested parties around the world."
Mr. Verzura went on to say, "The application further strengthens United Cannabis' intellectual property position as well as our branded products. We've invested a lot of time and capital in the creation of our Prana line and the technologies that make it possible, and we intend to safeguard that innovation."
The processes included in the filing are integral to the Company's branded products, including the Prana Bio Nutrient Medicinals line, and comprise the application of strain specific ratio based cannabinoids, plant based extractions, and the use of cannabis derived terpenes in the medical and pharmaceutical delivery methods including capsules, sublinguals, topicals, transdermal patches, edibles, aerosol sprays, aromatherapy, suppositories, and vaporization.
PCT is an international treaty that provides patent protection simultaneously in more than 145 Contracting States through a single application, rather than filing separate national or regional patent applications. The acceptance of the application by PCT establishes a filing date in all contracting states, providing the Company with a precedent against any future competing filings.
About United Cannabis Corporation
United Cannabis Corporation was founded to provide leadership in the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits through the use of cannabis-based research, products and services. The Company has established affiliate relationships with Harborside, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, Cannabinoid Research & Development, DNA Genetics, and Emotek. For further information, please visit www.unitedcannabis.us.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
SOURCE: United Cannabis Corporation